Skip to content

Clinical trials

Phase 1/2 Colorectal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Clear all

474 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20016
20024
20035
20047
20057
20069
200712
200813
200914
201015
20117
201217
20136
201416
201511
201622
201717
201830
201923
202027
202128
202227
202329
202432
202533
202638

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174
Recruiting108
Terminated60
Unknown status50
Active, not recruiting43
Not yet recruiting21
Withdrawn15
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
M.D. Anderson Cancer Center9
Bristol-Myers Squibb8
Incyte Corporation6
Roswell Park Cancer Institute6
Sun Yat-sen University6
Revolution Medicines, Inc.5
University of Southern California5
AstraZeneca4
Gilead Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms474
Carcinoma, Non-Small-Cell Lung93
Colonic Neoplasms76
Pancreatic Neoplasms74
Stomach Neoplasms64
Neoplasm Metastasis59
Ovarian Neoplasms58
Rectal Neoplasms57
Breast Neoplasms49
Neoplasms49

Trials

Showing 76 to 100 of 474. Each trial links to its page on Pharma Observatory.

374 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.